Join the Allergies group to help and get support from people like you.
Allergies News (Page 4)
Related terms: Allergy, Dust Mite Allergy
Anti- Seizure Meds Are Crucial, But Can Trigger Severe Reactions
MONDAY, June 24, 2024 – Specific steps can be taken to reduce the risk of potentially fatal reactions to anti-seizure medications, researchers report in a new review. Performing blood tests, asking...
Peanut Consumption Starting in Infancy Provides Lasting Tolerance
THURSDAY, May 30, 2024 – Peanut consumption starting in infancy and continuing to age 5 years provides lasting tolerance into adolescence, according to a study published in the June issue of NEJM...
Early Exposure to Peanuts Can Prevent Long-Term Allergy
WEDNESDAY, May 29, 2024 – Feeding kids peanuts early in childhood can drastically reduce their risk of developing a peanut allergy, a new clinical trial reports. Children regularly fed peanut...
Your Allergy Meds Come With Hazards: Be Aware
SATURDAY, May 18, 2024 – People with seasonal allergies often turn to over-the-counter and prescription medicines to relieve symptoms like coughing, sneezing, runny nose, congestion and itchy eyes,...
For Parents of Kids with Food Allergies, Social Media Can Bring Support -- and Stress
WEDNESDAY, May 1, 2024 – Having a child with food allergies isn't easy to manage, and now new research shows that most of these parents turn to social media for medical advice. When they do, some of...
U.S. FDA Approves ALK's Odactra (House Dust Mite Allergen Extract) Tablet for Sublingual Use as Immunotherapy for Adolescents
Odactra is now indicated to treat house dust mite (HDM)-induced allergic rhinitis, with or without conjunctivitis, in persons 12 through 17 years of age, in addition to adults 18 through 65 years of...
FDA Medwatch Alert: FDA Alerts Patients and Health Care Professionals that Some EpiPen Auto-Injectors May Not Readily Slide Out of Carrier Tube
[11/2/2018] FDA is alerting patients, caregivers and health care professionals that the labels attached to some EpiPen 0.3mg and EpiPen Jr 0.15mg auto-injectors, and the authorized generic versions,...
Adamis Pharmaceuticals Receives FDA Approval for Its Lower Dose Symjepi Product
SAN DIEGO, Sept. 27, 2018 (GLOBE NEWSWIRE) – Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) (“Adamis”) today announced that the U.S. Food and Drug Administration (“FDA”) has approved Adamis’ lower...
FDA Approves Odactra for House Dust Mite Allergies
March 1, 2017 – The U.S. Food and Drug Administration today approved Odactra, the first allergen extract to be administered under the tongue (sublingually) to treat house dust mite (HDM)-induced...
Sanofi's Xyzal Allergy 24HR Approved for Over-the-Counter Use
BRIDGEWATER, N.J., Feb. 1, 2017 /PRNewswire/ – Sanofi announced today that the U.S. Food and Drug Administration (FDA) approved Xyzal Allergy 24HR as an over-the-counter (OTC) treatment for the...
FDA Approves Flonase Sensimist Allergy Relief
WARREN, N.J. 2 August 2016 – GSK Consumer Healthcare announced today that the U.S. Food and Drug Administration (FDA) has approved Flonase® Sensimist™ Allergy Relief (fluticasone furoate, 27.5 mcg sp...
FDA Medwatch Alert: Auvi-Q (epinephrine injection, USP): Recall - Potential Inaccurate Dosage Delivery
ISSUE: Sanofi US is voluntarily recalling all Auvi-Q (epinephrine injection, USP). The recall involves all Auvi-Q currently on the market and includes both the 0.15 mg and 0.3 mg strengths for...
FDA Approves Flonase Allergy Relief for Sale Over-the-Counter in the United States
London UK & Parsippany, US - Thursday 24 July 2014, GlaxoSmithKline plc (LSE/NYSE: GSK) today announced that the U.S. Food and Drug Administration (FDA) has approved Flonase Allergy Relief...
FDA Approves Sanofi's Nasacort Allergy 24HR for Over-the-Counter Use
Paris, France, October 11, 2013 — Sanofi announced today that the U.S. Food and Drug Administration (FDA) approved Nasacort Allergy 24HR nasal spray as an over-the-counter (OTC) treatment for s...
FDA Approves Tris Pharma's New Drug Application for Karbinal ER
MONMOUTH JUNCTION, N.J., April 3, 2013 /PRNewswire/ – Tris Pharma, a specialty pharmaceutical company focused on developing innovative drug delivery technologies, today announced that the U.S. Food...
Further information
Related condition support groups
Hay Fever, Allergic Rhinitis, Allergic Reactions
Related drug support groups
prednisone, Benadryl, hydroxyzine, methylprednisolone, triamcinolone, Zyrtec, diphenhydramine, Allegra, loratadine, view more... promethazine, cetirizine, prednisolone, Vistaril, Phenergan, dexamethasone, pseudoephedrine, phenylephrine, Atarax, epinephrine, fexofenadine, montelukast, desonide, cyproheptadine